Atlas Trials

The Treatment of Patients With Type 1 Diabetes Mellitus With Autologous Tolerogenic Dendritic Cells

Clinical trial NCT05207995 · COMPLETED

Trial details

NCT number
NCT05207995
Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2022-03-01
Primary completion
2023-12-26
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.